PATENT CLAIM ANALYSIS

Application Number: 16272934
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["544", "281000"]

Abstract:
The invention concerns novel substituted pyrazolo- and triazolo-pyrimidine compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.

Claim (Index 4):
The compound as claimed in  claim 3  wherein R 1  is CH 3  or CH 2 CH 3 , and R 1  is hydrogen, and R 2  is C 3-6 alkyl and R 3  is CH 3 .

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.53846
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15570054', '15534442', '12293545', '11569108', '12988891']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7763918525612453
- 35 USC 102 Novelty (BERT): 0.5693617873300977
- Combined Prediction Score: 0.7556888460381306
- Mean Citation Score: 300.244926
- Max Citation Score: 431.0718
- Similarity Product: 427.5541020699978

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test